Analysis of Irregular Blood Group Antibody Distribution and Blood Transfusion Efficacy in Patients with Malignant Tumor.
10.19746/j.cnki.issn.1009-2137.2023.01.033
- Author:
Dong REN
1
;
Hong-Bin ZHAO
1
;
Xiao-Jun GUO
1
;
Xue-Hua HE
2
Author Information
1. Department of Blood Transfusion, Shanxi Bethune Hospital, Taiyuan 030032, Shanxi Province, China.
2. Department of Blood Transfusion, Shanxi Bethune Hospital, Taiyuan 030032, Shanxi Province, China,E-mail: rd574544711@163.com.
- Publication Type:Journal Article
- Keywords:
blood transfusion efficacy;
cross matching test;
irregular blood group antibody;
malignant tumor
- MeSH:
Humans;
Male;
Female;
Blood Transfusion;
Blood Group Antigens;
Rh-Hr Blood-Group System;
Antibodies;
Neoplasms/therapy*;
Isoantibodies
- From:
Journal of Experimental Hematology
2023;31(1):209-214
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the distribution of irregular blood group antibodies in patients with malignant tumors, and to analyze the relationship between it and efficacy of blood transfusion in patients.
METHODS:5 600 patients with malignant tumors treated in Shanxi Bethune Hospital from January 2019 to December 2021 were selected as the research subjects. All patients received blood transfusion, and cross matching test was conducted before blood transfusion, irregular antibody results of patients were tested; the irregular distribution of blood group antibodies was observed, and the relationship between it and efficacy of blood transfusion in patients was analyzed.
RESULTS:Among 5 600 patients with malignant tumors, 96 cases were positive for irregular antibody, and the positive rate was 1.71%; the main blood group systems involved in the irregular antibody positive of 96 patients with malignant tumors were RH, MNSs and Duffy system, among which Rh blood group was the most common, and the proportion of anti-E was the highest; among the malignant tumor patients with positive blood group irregular antibody, the proportion of female was higher than that of male; the proportion of patients aged >60 years was the highest, followed by patients aged >40 and ≤50 years, and the proportion of patients aged 18-30 years was the lowest; the patients with positive blood group irregular antibody were mainly in blood system (including lymphoma), digestive system, reproductive and urinary system; the positive rate of irregular antibody of patients in the ineffective group was higher than that of patients in the effective group, the difference was statistically significant (P<0.05). Logistic regression analysis results showed that, irregular antibody positive was a risk factor for ineffective blood transfusion in patients with malignant tumor (OR>1, P<0.05).
CONCLUSION:The irregular blood group antibody positive of patients with malignant tumor are mostly female, and the proportion of patients aged >60 is the highest, which is mainly distributed in malignant tumors of blood system, digestive system and urogenital system, and the positive blood group irregular antibody is related to the efficacy of blood transfusion in patients.
